Menu
GeneBe

UBR4

ubiquitin protein ligase E3 component n-recognin 4, the group of Armadillo like helical domain containing|Ubiquitin protein ligase E3 component n-recognins

Basic information

Region (hg38): 1:19074509-19210266

Previous symbols: [ "ZUBR1" ]

Links

ENSG00000127481NCBI:23352OMIM:609890HGNC:30313Uniprot:Q5T4S7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UBR4 gene.

  • Inborn genetic diseases (143 variants)
  • not provided (121 variants)
  • UBR4-related condition (3 variants)
  • Short stature (3 variants)
  • UBR4-associated neurodevelopmental syndrome (2 variants)
  • Developmental disorder (1 variants)
  • Neurodevelopmental disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBR4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
41
clinvar
22
clinvar
63
missense
154
clinvar
10
clinvar
5
clinvar
169
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
15
5
21
non coding
10
clinvar
10
Total 0 0 156 51 37

Variants in UBR4

This is a list of pathogenic ClinVar variants found in the UBR4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-19074837-G-T not specified Uncertain significance (Feb 12, 2024)546592
1-19074873-G-C not specified Uncertain significance (Feb 12, 2024)546593
1-19074877-G-A UBR4-related disorder Likely benign (Jul 30, 2019)743750
1-19076793-A-G not specified Uncertain significance (Jun 05, 2023)2556570
1-19076803-G-C not specified Uncertain significance (Feb 28, 2023)2490518
1-19076827-T-C not specified Uncertain significance (Jan 17, 2024)3185824
1-19076858-G-A UBR4-related disorder Benign (Jan 29, 2020)3038747
1-19076883-G-A not specified Uncertain significance (Nov 07, 2022)2376008
1-19076890-T-C not specified Uncertain significance (Nov 09, 2021)2259901
1-19076896-G-A not specified Uncertain significance (Mar 17, 2023)2526399
1-19076906-C-A UBR4-related disorder Benign (Sep 17, 2019)3050405
1-19078028-C-T Uncertain significance (Apr 01, 2023)156527
1-19078034-G-A not specified Uncertain significance (Oct 26, 2022)2320452
1-19078035-C-T not specified Uncertain significance (Feb 15, 2023)2472933
1-19078036-G-A Likely benign (Jun 15, 2018)752812
1-19078075-G-C UBR4-related disorder Benign (Jun 03, 2019)777888
1-19081341-G-A UBR4-related disorder Likely benign (Jun 10, 2019)741319
1-19081374-C-T not specified Uncertain significance (Mar 01, 2023)2492471
1-19081376-C-T not specified Uncertain significance (Jun 24, 2022)2296445
1-19081403-C-T not specified Uncertain significance (Dec 13, 2023)3185822
1-19081412-T-C not specified Uncertain significance (Feb 03, 2022)2356149
1-19081412-T-G not specified Uncertain significance (Apr 20, 2023)2564392
1-19081419-G-A not specified Uncertain significance (Nov 03, 2022)3185821
1-19081422-T-C not specified Uncertain significance (Nov 29, 2021)2223772
1-19081520-G-A Likely benign (Mar 01, 2023)2638409

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UBR4protein_codingprotein_codingENST00000375254 106135771
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.002.04e-301257120361257480.000143
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense5.6820002.85e+30.7010.00016633939
Missense in Polyphen6381172.30.5442113707
Synonymous-0.45211421.12e+31.020.000065610271
Loss of Function13.9162550.06280.00001293054

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003620.000239
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0002770.000277
European (Non-Finnish)0.0001770.000176
Middle Eastern0.00005440.0000544
South Asian0.00009810.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization. Regulates integrin-mediated signaling. May play a role in activation of FAK in response to cell-matrix interactions. Mediates ubiquitination of ACLY, leading to its subsequent degradation. {ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:23932781}.;
Pathway
Viral carcinogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Neutrophil degranulation;Innate Immune System;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation (Consensus)

Recessive Scores

pRec
0.127

Intolerance Scores

loftool
0.297
rvis_EVS
-7.5
rvis_percentile_EVS
0.01

Haploinsufficiency Scores

pHI
0.257
hipred
Y
hipred_score
0.625
ghis
0.643

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.911

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ubr4
Phenotype
growth/size/body region phenotype; cellular phenotype; embryo phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
ubiquitin-dependent protein catabolic process;viral process;protein ubiquitination;neutrophil degranulation
Cellular component
nucleoplasm;centrosome;cytosol;plasma membrane;membrane;integral component of membrane;specific granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane
Molecular function
ubiquitin-protein transferase activity;protein binding;calmodulin binding;zinc ion binding